Daiichi Sankyo Company Limited
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule that targets colony stimulating factor 1 rec… Read more
Daiichi Sankyo Company Limited (DSKYF) - Total Assets
Latest total assets as of December 2025: $3.83 Trillion USD
Based on the latest financial reports, Daiichi Sankyo Company Limited (DSKYF) holds total assets worth $3.83 Trillion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Daiichi Sankyo Company Limited - Total Assets Trend (2000–2025)
This chart illustrates how Daiichi Sankyo Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Daiichi Sankyo Company Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Daiichi Sankyo Company Limited's total assets of $3.83 Trillion consist of 55.3% current assets and 44.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 18.5% |
| Accounts Receivable | $619.10 Billion | 17.9% |
| Inventory | $514.91 Billion | 14.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $235.84 Billion | 6.8% |
| Goodwill | $108.43 Billion | 3.1% |
Asset Composition Trend (2000–2025)
This chart illustrates how Daiichi Sankyo Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Daiichi Sankyo Company Limited's current assets represent 55.3% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 18.5% of total assets in 2025, up from 0.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 17.9% of total assets.
Daiichi Sankyo Company Limited Competitors by Total Assets
Key competitors of Daiichi Sankyo Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367
|
China | CN¥1.52 Billion |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
|
China | CN¥13.11 Billion |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
|
China | CN¥774.73 Million |
|
PharmGen Science Inc
KO:004720
|
Korea | ₩331.46 Billion |
Daiichi Sankyo Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Daiichi Sankyo Company Limited generates 0.55x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Daiichi Sankyo Company Limited generates $8.56 in net profit.
Daiichi Sankyo Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.69 | 2.77 | 3.59 |
| Quick Ratio | 1.85 | 2.11 | 3.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.32 Trillion | $ 1.26 Trillion | $ 914.85 Billion |
Daiichi Sankyo Company Limited - Advanced Valuation Insights
This section examines the relationship between Daiichi Sankyo Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.20 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -0.1% |
| Total Assets | $3.46 Trillion |
| Market Capitalization | $37.02 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Daiichi Sankyo Company Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Daiichi Sankyo Company Limited's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Daiichi Sankyo Company Limited (2000–2025)
The table below shows the annual total assets of Daiichi Sankyo Company Limited from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $3.46 Trillion | -0.14% |
| 2024-03-31 | $3.46 Trillion | +37.95% |
| 2023-03-31 | $2.51 Trillion | +12.94% |
| 2022-03-31 | $2.22 Trillion | +6.53% |
| 2021-03-31 | $2.09 Trillion | -0.97% |
| 2020-03-31 | $2.11 Trillion | +0.84% |
| 2019-03-31 | $2.09 Trillion | +10.03% |
| 2018-03-31 | $1.90 Trillion | -0.90% |
| 2017-03-31 | $1.91 Trillion | +0.76% |
| 2016-03-31 | $1.90 Trillion | -4.12% |
| 2015-03-31 | $1.98 Trillion | +6.92% |
| 2014-03-31 | $1.85 Trillion | +10.04% |
| 2013-03-31 | $1.68 Trillion | +8.41% |
| 2012-03-31 | $1.55 Trillion | +5.00% |
| 2011-03-31 | $1.48 Trillion | -0.62% |
| 2010-03-31 | $1.49 Trillion | -0.34% |
| 2009-03-31 | $1.49 Trillion | +0.45% |
| 2008-03-31 | $1.49 Trillion | -9.10% |
| 2007-03-31 | $1.64 Trillion | +2.55% |
| 2006-03-31 | $1.60 Trillion | +63.50% |
| 2005-03-31 | $976.23 Billion | +5.28% |
| 2004-03-31 | $927.24 Billion | +1.25% |
| 2003-03-31 | $915.79 Billion | -0.06% |
| 2002-03-31 | $916.30 Billion | -5.04% |
| 2001-03-31 | $964.90 Billion | +4.69% |
| 2000-03-31 | $921.66 Billion | -- |